Prof Carl Kirkpatrick

Related Grants and Projects

• Participant in Antibiotic dosing in the (funded by National Health and Medical Research Council)
• Participant in Combating bacterial ‘superbugs‘ by innovative dosing strategies that combine available antibiotics to prevent resistance (funded by National Health and Medical Research Council)
• Participant in Determining the clinical effectiveness of antiviral drugs against oseltamivir- and laninamivir-resistant influenza viruses in animal models (funded by National Health and Medical Research Council)
• Participant in Improving the treatment of breathlessness – a phase III randomised, controlled trial of sustained release morphine for the symptomatic treatment of chronic refractory breathlessness. A Palliative Care Clinical Studies Collaborative study (funded by National Health and Medical Research Council)
• Participant in Innovative dosing approaches to maximise bacterial killing and prevent resistance in septic critically ill patients. (funded by National Health and Medical Research Council)